Lantern Pharma

/Lantern Pharma

Follow-on

Lantern Pharma

Biotechnology

We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from our targeted oncology therapies.

Symbol

LTRN

Last Closing Price
$15.55

Shares
2,613,695

Anticipated Date
January 15, 2021

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Lantern Pharma, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange